Literature DB >> 12030787

Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.

M K Ozer1, E Sahna, M Birincioglu, A Acet.   

Abstract

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 (AT (1)) receptor blockers improve ischemia-reperfusion induced arrhythmias and infarct size in several animal models. However, the effects of pretreatment with ACEIs or AT (1) receptor blockers on acute myocardial infarct size and arrhythmias are controversial. Thus, we sought to assess the comparative effects of pretreatment with ACEI captopril and AT (1)-receptor blocker losartan on myocardial infarct size and arrhythmias in a rat model of ischemia-reperfusion. We randomly assigned 92 male Wistar rats for arrhythmias ( n= 60) and necrosis ( n= 32) experiments. To produce arrhythmia, the left main coronary artery was occluded for 7 min, followed by 7 min of reperfusion and to produce necrosis, the the left main coronary artery was occluded for 30 min, followed by 120 min of reperfusion. Captopril (3 mg kg (-1)) and losartan (0.2 and 2 mg kg (-1)) were given intravenously 10 min before occlusion. Captopril reduced the incidences of ventricular fibrillation (VF) and mortality associated with irreversible VF, whereas the studied doses of losartan did not. Captopril also decreased the number of ventricular beats on reperfusion. Losartan 2 mg kg (-1) reduced both the number of ventricular premature beats and the incidence of ventricular tachycardia (VT) on reperfusion, while losartan at dose of 0.2 mg kg (-1) had no effect on these arrhythmias. Compared to the control group, both captopril and losartan reduced myocardial infarct size in the rat model of ischemia-reperfusion, but this was statistically significant for captopril only. In this experimental model, although captopril did not reduce the incidence of reperfusion-induced VT, it was more effective than the AT (1)-receptor blocker losartan at preventing mortality associated with irreversible VF and to reduce myocardial infarct size in rat model of ischemia-reperfusion. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030787     DOI: 10.1006/phrs.2002.0965

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats.

Authors:  Hakan Parlakpinar; Mehmet Kaya Ozer; Ahmet Acet
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

Review 2.  Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.

Authors:  Giovanni F M Strippoli; Maria Craig; Jonathan J Deeks; Francesco Paolo Schena; Jonathan C Craig
Journal:  BMJ       Date:  2004-09-30

3.  Effects of tamoxifen on myocardial ischemia-reperfusion injury model in ovariectomized rats.

Authors:  Rauf Onur Ek; Yuksel Yildiz; Serpil Cecen; Cigdem Yenisey; Tulay Kavak
Journal:  Mol Cell Biochem       Date:  2007-11-03       Impact factor: 3.396

4.  Chronic Losartan Treatment Up-Regulates AT1R and Increases the Heart Vulnerability to Acute Onset of Ischemia and Reperfusion Injury in Male Rats.

Authors:  Minwoo A Song; Chiranjib Dasgupta; Lubo Zhang
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

5.  Effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 and interleukin-33 in patients with ST-segment elevation myocardial infarction.

Authors:  Li Zhang; Miao Hu; Yuan Chen; Yijun Wang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.